Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1952 2
1968 1
1973 2
1975 1
1984 1
1986 1
1987 1
1989 2
1990 1
1991 2
1993 2
1995 2
1996 1
1997 2
1998 2
1999 5
2000 5
2001 3
2002 2
2003 6
2004 2
2005 5
2006 7
2007 8
2008 4
2009 13
2010 28
2011 24
2012 28
2013 34
2014 36
2015 44
2016 45
2017 39
2018 48
2019 49
2020 74
2021 80
2022 60
2023 63
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

663 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for garcia gutierrez
Search for Narcisa Gutierrez instead (1 results)
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Réa D, Mauro MJ, Boquimpani C, Minami Y, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Abdo A, Fogliatto LM, Kim DDH, le Coutre P, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Sasaki K, Chee L, García-Gutiérrez V, Cortes JE, Aimone P, Allepuz A, Quenet S, Bédoucha V, Hochhaus A. Réa D, et al. Among authors: garcia gutierrez v. Blood. 2021 Nov 25;138(21):2031-2041. doi: 10.1182/blood.2020009984. Blood. 2021. PMID: 34407542 Free PMC article. Clinical Trial.
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Hochhaus A, Réa D, Boquimpani C, Minami Y, Cortes JE, Hughes TP, Apperley JF, Lomaia E, Voloshin S, Turkina A, Kim DW, Abdo A, Fogliatto LM, le Coutre P, Sasaki K, Kim DDH, Saussele S, Annunziata M, Chaudhri N, Chee L, García-Gutiérrez V, Kapoor S, Allepuz A, Quenet S, Bédoucha V, Mauro MJ. Hochhaus A, et al. Among authors: garcia gutierrez v. Leukemia. 2023 Mar;37(3):617-626. doi: 10.1038/s41375-023-01829-9. Epub 2023 Jan 30. Leukemia. 2023. PMID: 36717654 Free PMC article. Clinical Trial.
Hematuria Macroscopica En Pacientes Con Nefropatía Iga Tras Vacuna Para Sars-Cov-2.
Calle Garcia L, Martin Varas C, Urzola Rodriguez G, Marcos Hidalgo M, Rodriguez Gomez A, Molina Ordas A, Fidalgo Gonzalez V, Sanchez Garrote P, Garcia Gutierrez P, Garcia De Burgos M, Fernandez-Reyes Luis MJ. Calle Garcia L, et al. Among authors: garcia gutierrez p. Nefrologia (Engl Ed). 2021 Sep 29. doi: 10.1016/j.nefro.2021.09.005. Online ahead of print. Nefrologia (Engl Ed). 2021. PMID: 34602693 Free PMC article. Spanish. No abstract available.
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
Brümmendorf TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, Clark RE, le Coutre P, Garcia-Gutierrez V, Chuah C, Kota V, Lipton JH, Rousselot P, Mauro MJ, Hochhaus A, Hurtado Monroy R, Leip E, Purcell S, Yver A, Viqueira A, Deininger MW; BFORE study investigators. Brümmendorf TH, et al. Among authors: garcia gutierrez v. Leukemia. 2022 Jul;36(7):1825-1833. doi: 10.1038/s41375-022-01589-y. Epub 2022 May 28. Leukemia. 2022. PMID: 35643868 Free PMC article. Clinical Trial.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH. Cortes JE, et al. Among authors: garcia gutierrez v. J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1. J Clin Oncol. 2018. PMID: 29091516 Free PMC article. Clinical Trial.
Editorial: Epidemiological trends in hematological malignancies.
de Lima M, Castillo J, Merli M, Garcia-Gutierrez V. de Lima M, et al. Among authors: garcia gutierrez v. Front Oncol. 2023 Feb 14;13:1151774. doi: 10.3389/fonc.2023.1151774. eCollection 2023. Front Oncol. 2023. PMID: 36865813 Free PMC article. No abstract available.
SUMO control of nervous system development.
García-Gutiérrez P, García-Domínguez M. García-Gutiérrez P, et al. Semin Cell Dev Biol. 2022 Dec;132:203-212. doi: 10.1016/j.semcdb.2021.11.022. Epub 2021 Nov 27. Semin Cell Dev Biol. 2022. PMID: 34848148 Review.
663 results